|
|
The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2021: |
|
|
New Study published validating further Nevisense indication, Non-melanoma Skin Cancer |
|
|
Interim report |
|
|
SciBase announces changes to the Management team |
|
|
Positive step for US reimbursement of Nevisense |
|
|
SciBase releases next generation platform, Nevisense Go. |
|
|
SciBase Holding AB announces the outcome of the exercise of warrants of series TO1 |
|
|
Exercise price for warrants of series TO1 in SciBase Holding AB determined and the subscription period commence on 5 October 2020 |
|
|
Letter from the CEO |
|
|
New Clinical Studies show Improved Melanoma Detection by US clinicians with Nevisense |
